Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
10
self-reported 2–10 band
Founded
2017
9 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
3
Non equity assistance · Jul 2023
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
BIOTOME PTY LTD
ABN69619107818
Legal entities
Show as table · Biotome Pty Ltd: 1 registry entity
| BIOTOME PTY LTD | ABN 69619107818 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Biotome develops antibody tests using next generation technology and precision immunology to address the problems of traditional serology tests.
Our antibody tests surpass current antibody screening with enhanced precision and more detailed disease information.
We use an efficient, scalable process of discovering precision markers for diagnosis, applicable to any disease that triggers an immune response.
The patentable peptide markers are fundamental to our commercialization process. IP protection carves out space for our precision diagnostics in a market dominated by lower-accuracy, non-proprietary tests from huge corporations.
Biotome also offers cutting-edge expertise in marker identification, patenting, and precision immunology data analytics to research companies and organizations.
Specialties
All 14 specialties
- Immunology
- Diagnostics
- Biosensors
- Cancer
- Infectious Disease
- Virus
- Epitope
- Serology
- Next Generation Serology
- Precision Immunology
- Point-of-Care Tests
- Antibody Test
- Stomach Cancer
- Helicobacter
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU6 Verdun St; Perth, Western Australia 6009Primary
Grid intelligence Members
Funding
Rounds3
Round typeNon equity assistance · non-equity funding
Amount (USD)not recorded
Stage rank1
Investors named1
Since last round2 yr 6 mo
Funding
Show as table · 3 funding rounds
| Rounds | 3 |
|---|---|
| Axis | 2017 to 2026 |
| Non equity assistance · 6 Jul 2023 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Biotome Pty Ltd?
One Western Australia entity on the ABR: BIOTOME PTY LTD (ABN 69 619 107 818), high confidence.
How many people work at Biotome Pty Ltd?
10 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Biotome Pty Ltd have offices?
One address on record, Australia only. Primary: 6 Verdun St, Perth, Western Australia 6009.
Has Biotome Pty Ltd raised funding?
Three rounds. Latest 6 July 2023: non equity assistance, investor MedTech Innovator, no amount recorded.
What does Biotome Pty Ltd list as its specialties?
14 tags on the brand's own list, among them cancer, immunology and diagnostics.
Which companies are listed alongside Biotome Pty Ltd?
11 profiles list Biotome Pty Ltd as a peer — 84th percentile in Biotechnology Research. It lists ten peers of its own. Reliis and Zelira Therapeutics list it back.